Wiest Verena, Eisenbarth Ingrid, Schmegner Claudia, Krone Winfrid, Assum Günter
Abteilung Humangenetik, Universität Ulm, Ulm, Germany.
Hum Mutat. 2003 Dec;22(6):423-7. doi: 10.1002/humu.10272.
Neurofibromatosis type 1 (NF1), an autosomal dominantly-inherited disorder, is mainly characterized by the occurrence of multiple dermal neurofibromas and is caused by mutations in the NF1 gene, a tumor suppressor gene. The variable expressivity of the disease and the lack of a genotype/phenotype correlation prevents any prediction of patient outcome and points to the action of genetic factors in addition to stochastic factors modifying the severity of the disease. The analysis of somatic NF1 gene mutations in neurofibromas from NF1 patients revealed that each neurofibroma results from an individual second hit mutation, indicating that factors that influence somatic mutation rates may be regarded as potential modifiers of NF1. A mutational screen of numerous neurofibromas from two NF1 patients presented here revealed a predominance of point mutations, small deletions, and insertions as second hit mutations in both patients. Seven novel mutations are reported. Together with the results of studies that showed LOH as the predominant second hit in neurofibromas of other patients, our results suggest that in different patients different factors may influence the somatic mutation rate and thereby the severity of the disease.
1型神经纤维瘤病(NF1)是一种常染色体显性遗传病,主要特征是出现多发性皮肤神经纤维瘤,由肿瘤抑制基因NF1基因突变引起。该疾病的可变表达性以及缺乏基因型/表型相关性,使得无法对患者预后进行任何预测,这表明除了影响疾病严重程度的随机因素外,还有遗传因素在起作用。对NF1患者神经纤维瘤中体细胞NF1基因突变的分析表明,每个神经纤维瘤都源于单个二次打击突变,这表明影响体细胞突变率的因素可能被视为NF1的潜在修饰因子。本文对两名NF1患者的众多神经纤维瘤进行的突变筛查显示,点突变、小缺失和插入作为两名患者的二次打击突变占主导地位。报告了七个新突变。结合其他患者神经纤维瘤中以杂合性缺失作为主要二次打击的研究结果,我们的结果表明,在不同患者中,不同因素可能影响体细胞突变率,进而影响疾病的严重程度。